Recent Finacing
Recent Raise
DiscGenics is a clinical-stage regenerative medicine company developing IDCT, an allogeneic, homologous injectable cell therapy for mild-to-moderate degenerative disc disease, and scaling cell manufacturing for clinical/commercial production.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
